Drug Shortage Report for TEVA-RISEDRONATE
Report ID | 1607 |
Drug Identification Number | 02413809 |
Brand name | TEVA-RISEDRONATE |
Common or Proper name | RISEDRONATE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 3 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-02-01 |
Estimated end date | 2017-04-07 |
Actual end date | 2017-05-01 |
Shortage status | Resolved |
Updated date | 2017-10-10 |
Company comments | 1's pack size available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-10-10 | French | Compare |
v4 | 2017-10-10 | English | Compare |
v3 | 2017-03-13 | French | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 5 of 5